Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other biologically active compounds. Its boronic acid functional group enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds. Commonly employed in research settings to design drug candidates targeting cancer, inflammation, and central nervous system disorders. Also utilized in the preparation of boron-containing molecules for use in neutron capture therapy and as enzyme inhibitors.